Education
About Us
Working with TipRanks
Follow Us
Revolution Medicines (RVMD)
NASDAQ:RVMD
RVMD Analyst Ratings
Strong Buy
17 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
RVMD Stock 12 Month Forecast
Average Price Target
$141.67
▲(42.91% Upside)
| Highest Price Target$170.00 | Average Price Target$141.67 | Lowest Price Target$115.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Guggenheim
$160
Buy
61.40%
Upside
Reiterated
03/18/26
UBS
$145
Buy
46.27%
Upside
Reiterated
03/18/26
Jefferies
$88→$140
Buy
41.23%
Upside
Initiated
03/16/26
Evercore ISI
$140
Buy
41.23%
Upside
Reiterated
03/09/26
RBC Capital
$140
Buy
41.23%
Upside
Reiterated
03/09/26
Truist Financial
―
Buy
―
Reiterated
03/09/26
Bank of America Securities
$115
Buy
16.01%
Upside
Reiterated
03/06/26
J.P. Morgan
$92→$125
Buy
26.10%
Upside
Reiterated
03/03/26
Needham
$150→$145
Buy
46.27%
Upside
Reiterated
02/26/26
Piper Sandler
$75→$120
Buy
21.05%
Upside
Reiterated
02/26/26
Oppenheimer
$150
Buy
51.32%
Upside
Downgraded
02/26/26
Wells Fargo
$100→$144
Buy
45.26%
Upside
Reiterated
02/26/26
Mizuho Securities
$143→$140
Buy
41.23%
Upside
Reiterated
02/26/26
Wedbush
$147
Buy
48.29%
Upside
Reiterated
02/26/26
LifeSci Capital
$144
Buy
45.26%
Upside
Reiterated
02/25/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Guggenheim
$160
Buy
61.40%
Upside
Reiterated
03/18/26
UBS
$145
Buy
46.27%
Upside
Reiterated
03/18/26
Jefferies
$88→$140
Buy
41.23%
Upside
Initiated
03/16/26
Evercore ISI
$140
Buy
41.23%
Upside
Reiterated
03/09/26
RBC Capital
$140
Buy
41.23%
Upside
Reiterated
03/09/26
Truist Financial
―
Buy
―
Reiterated
03/09/26
Bank of America Securities
$115
Buy
16.01%
Upside
Reiterated
03/06/26
J.P. Morgan
$92→$125
Buy
26.10%
Upside
Reiterated
03/03/26
Needham
$150→$145
Buy
46.27%
Upside
Reiterated
02/26/26
Piper Sandler
$75→$120
Buy
21.05%
Upside
Reiterated
02/26/26
Oppenheimer
$150
Buy
51.32%
Upside
Downgraded
02/26/26
Wells Fargo
$100→$144
Buy
45.26%
Upside
Reiterated
02/26/26
Mizuho Securities
$143→$140
Buy
41.23%
Upside
Reiterated
02/26/26
Wedbush
$147
Buy
48.29%
Upside
Reiterated
02/26/26
LifeSci Capital
$144
Buy
45.26%
Upside
Reiterated
02/25/26
Best Analysts Covering Revolution Medicines
3 Months
xxx
Success Rate
11/16 ratings generated profit
Average Return
+18.03%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 68.75% of your transactions generating a profit, with an average return of +18.03% per trade.
1 Year
Success Rate
13/16 ratings generated profit
Average Return
+72.76%
Copying Robert Burns's trades and holding each position for 1 Year would result in 81.25% of your transactions generating a profit, with an average return of +72.76% per trade.
2 Years
xxx
Success Rate
16/16 ratings generated profit
Average Return
+127.99%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +127.99% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
RVMD Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
19
7
6
5
7
Buy
35
36
43
45
47
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
54
43
49
50
54
Each month's total comprises the sum of three months' worth of ratings.
RVMD Financial Forecast
RVMD Stock Forecast FAQ
What is RVMD’s average 12-month price target, according to analysts?
Based on analyst ratings, Revolution Medicines’s 12-month average price target is 141.67.
What is RVMD’s upside potential, based on the analysts’ average price target?
Revolution Medicines has 42.91% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RVMD a Buy, Sell or Hold?
Revolution Medicines has a consensus rating of Strong Buy which is based on 17 buy ratings, 0 hold ratings and 0 sell ratings.
What is Revolution Medicines’s price target?
The average price target for Revolution Medicines is 141.67. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $170.00 ,the lowest forecast is $115.00. The average price target represents 42.91% Increase from the current price of $99.13.
The highest analyst price target is $170.00 ,the lowest forecast is $115.00. The average price target represents 42.91% Increase from the current price of $99.13.
What do analysts say about Revolution Medicines?
Revolution Medicines’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.
How can I buy shares of RVMD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.